A recent study by Weichert et al compared 4 KRAS mutation assays of primary colorectal cancer samples and metastases using DNA extracted from tumor sections on glass slides and similarly determined that the assay techniques were generally in good agreement [19]. This evidence concerns the gene KRAS and colorectal cancer.